Company logo

OFIX - Orthofix Medical Inc.

NASDAQ -> Healthcare -> Medical Devices
Lewisville, United States
Type: Equity

OFIX price evolution
OFIX
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $37.76 $33.66 $37.61 $49.97
Short term investments
Net receivables $128.1 $114.12 $112.32 $113.31
Inventory $222.17 $221.75 $222.47 $221.93
Total current assets $420.44 $393.7 $399.35 $410.04
Long term investments
Property, plant & equipment $159.06 $152.69 $140.58 $136.82
Goodwill & intangible assets $312.42 $315.79 $317.73 $324.84
Total noncurrent assets $504.87 $511.96 $501.94 $507.1
Total investments
Total assets $925.32 $905.65 $901.29 $917.14
Current liabilities
Accounts payable $58.36 $53.26 $51.35 $45.88
Deferred revenue
Short long term debt $1.96 $0.69 $0.68 $0.66
Total current liabilities $165.22 $152.53 $141.8 $137.57
Long term debt $111.64 $88.72 $69.89 $64.07
Total noncurrent liabilities $161.36 $137.64 $119.5 $115.41
Total debt $113.6 $89.41 $70.57 $64.73
Total liabilities $326.58 $290.17 $261.3 $252.98
Shareholders' equity
Retained earnings -$150.14 -$127.97 -$99.11 -$59.69
Other shareholder equity -$1.29 -$1.86 -$0.11 -$0.95
Total shareholder equity $598.73 $615.48 $639.99 $664.16
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $37.76 $50.7 $87.85 $96.82
Short term investments
Net receivables $128.1 $82.86 $78.56 $72.42
Inventory $222.17 $100.15 $82.97 $84.64
Total current assets $420.44 $255.99 $269.52 $270.38
Long term investments
Property, plant & equipment $159.06 $65.02 $59.25 $63.61
Goodwill & intangible assets $312.42 $118.7 $123.98 $144.53
Total noncurrent assets $504.87 $202.64 $207.1 $255.48
Total investments
Total assets $925.32 $458.63 $476.62 $525.86
Current liabilities
Accounts payable $58.36 $27.6 $26.46 $23.12
Deferred revenue
Short long term debt $1.96 $0.65 $2.59 $0.51
Total current liabilities $165.22 $83.62 $105.83 $103.9
Long term debt $111.64 $19.24 $19.89 $22.34
Total noncurrent liabilities $161.36 $38.15 $33.86 $65.1
Total debt $113.6 $19.89 $22.48 $22.85
Total liabilities $326.58 $121.77 $139.69 $169
Shareholders' equity
Retained earnings -$150.14 $1.25 $21 $59.38
Other shareholder equity -$1.29 -$1.48 $3.25
Total shareholder equity $598.73 $336.86 $336.93 $356.86
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $200.41 $184.01 $187.02 $175.2
Cost of revenue $63.78 $64.24 $67.47 $64.88
Gross Profit $136.63 $119.76 $119.55 $110.33
Operating activities
Research & development $18.94 $18.56 $19.42 $23.31
Selling, general & administrative $132.28 $122.08 $133.43 $142.6
Total operating expenses $154.94 $144.21 $156.18 $170.04
Operating income -$18.32 -$24.45 -$36.63 -$59.71
Income from continuing operations
EBIT -$17.55 -$26.81 -$36.65 -$59.04
Income tax expense $0.13 $0.47 $1.51 $0.61
Interest expense $4.5 $1.58 $1.27 $1.29
Net income
Net income -$22.17 -$28.86 -$39.43 -$60.94
Income (for common shares) -$22.17 -$28.86 -$39.43 -$60.94
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $746.64 $460.71 $464.48 $406.56
Cost of revenue $260.37 $123.54 $114.91 $101.89
Gross Profit $486.27 $337.17 $349.56 $304.67
Operating activities
Research & development $80.23 $49.06 $49.62 $39.06
Selling, general & administrative $530.39 $308.78 $290.67 $272.38
Total operating expenses $625.38 $350.44 $357.88 $310.94
Operating income -$139.11 -$13.27 -$8.31 -$6.27
Income from continuing operations
EBIT -$140.05 -$16.42 -$11.66 $2.12
Income tax expense $2.72 $2.04 $24.88 -$2.88
Interest expense $8.63 $1.29 $1.84 $2.48
Net income
Net income -$151.4 -$19.75 -$38.38 $2.52
Income (for common shares) -$151.4 -$19.75 -$38.38 $2.52
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$22.17 -$28.86 -$39.43 -$60.94
Operating activities
Depreciation $13.97 $13.1 $13.33 $12.67
Business acquisitions & disposals $29.42
Stock-based compensation $3.17 $6.27 $13.25 $13.02
Total cash flows from operations -$6.69 $0.48 -$5.52 -$34.02
Investing activities
Capital expenditures -$15.05 -$22.34 -$12.82 -$11.84
Investments
Total cash flows from investing -$15.05 -$22.34 -$12.82 $17.08
Financing activities
Dividends paid
Sale and purchase of stock $2.75 $2.38
Net borrowings $22.97 $18.84 $5.84 $17.94
Total cash flows from financing $25.28 $18.25 $5.81 $15.98
Effect of exchange rate $0.56 -$0.33 $0.17 $0.22
Change in cash and equivalents $4.09 -$3.94 -$12.36 -$0.73
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$151.4 -$19.75 -$38.38 $2.52
Operating activities
Depreciation $53.06 $29.02 $29.6 $30.55
Business acquisitions & disposals $29.42 -$1.37 -$1.25 -$25.24
Stock-based compensation $35.71 $18.44 $15.43 $16.21
Total cash flows from operations -$45.75 -$11.54 $18.48 $74.27
Investing activities
Capital expenditures -$62.05 -$23.16 -$19.59 -$17.09
Investments -$2.17 -$10
Total cash flows from investing -$33.13 -$24.53 -$23.01 -$52.33
Financing activities
Dividends paid
Sale and purchase of stock $5.13 $4.34 $8.82 $7.6
Net borrowings $65.59 -$2.69 -$1.49 -$1.86
Total cash flows from financing $65.32 -$0.08 -$3.62 $3.25
Effect of exchange rate $0.62 -$1 -$0.81 $1.24
Change in cash and equivalents -$12.94 -$37.15 -$8.97 $26.42
Fundamentals
Market cap $539.64M
Enterprise value $615.48M
Shares outstanding 37.16M
Revenue $746.64M
EBITDA -$86.98M
EBIT -$140.05M
Net Income -$151.40M
Revenue Q/Q 63.97%
Revenue Y/Y N/A
P/E ratio -3.56
EV/Sales 0.82
EV/EBITDA -7.08
EV/EBIT -4.39
P/S ratio 0.72
P/B ratio 0.90
Book/Share 16.14
Cash/Share 1.02
EPS -$4.07
ROA -16.59%
ROE -24.05%
Debt/Equity 0.55
Net debt/EBITDA -3.32
Current ratio 2.54
Quick ratio 1.20